Zepbound vs Wegovy : The global obesity epidemic has spurred the development of advanced pharmacological interventions, with Zepbound (tirzepatide) and Wegovy (semaglutide) emerging as frontrunners in weight management. Both medications, approved by the U.S. Food and Drug Administration (FDA) for chronic weight management, have transformed the landscape of obesity treatment. However, their differences in mechanism, … Read more